---
title: "Minds Study: E-Prescription Adoption Among Chronically Ill Patients | Minds"
canonical_url: "https://getminds.ai/studies/telehealth-e-rezept-adoption-de-2026"
last_updated: 2026-06-07
meta:
  description: "Learn how chronically ill patients evaluate the German e-prescription system. A data-dense Minds simulation reveals barriers and optimization potential for digital health platforms."
  "og:description": "Learn how chronically ill patients evaluate the German e-prescription system. A data-dense Minds simulation reveals barriers and optimization potential for digital health platforms."
  "og:title": "Minds Study: E-Prescription Adoption Among Chronically Ill Patients | Minds"
  "twitter:description": "Learn how chronically ill patients evaluate the German e-prescription system. A data-dense Minds simulation reveals barriers and optimization potential for digital health platforms."
  "twitter:title": "Minds Study: E-Prescription Adoption Among Chronically Ill Patients | Minds"
---

June 7, 2026·Consumer·Minds Team

# **Minds Study: E-Prescription Adoption Among Chronically Ill Patients**

Learn how chronically ill patients evaluate the German e-prescription system. A data-dense Minds simulation reveals barriers and optimization potential for digital health platforms.

[Download Benchmark Report](https://getminds.ai/?register=true&study=telehealth-e-rezept-adoption-de-2026)

## Methodology

A recent target audience simulation by Minds shows that 72 percent of chronically ill patients in Germany experience significant barriers when using the e-prescription app. These results were validated with data from the Statistisches Bundesamt and highlight that the complex Gematik infrastructure slows down digital adoption, while the physical health card remains the dominant redemption method.

**72**%

App usage barriers

**64**%

Preference for health card redemption

**31**%

Security concerns with EHR integration

Based on a simulated panel of 600 respondents. 85–95% accuracy validated against historical data.

## **Frequently asked questions**

### **How valid are the results of the Minds simulation compared to traditional patient panels?**

Minds achieves an average alignment of 85% to 95% with physical panels regarding preferences, language, and objections. For specific questions and precisely anchored segments, the alignment can even reach up to 100%.

### **How quickly does Minds deliver results, and where is the data processed?**

The entire target audience simulation is completed in under an hour, instead of taking several weeks like traditional studies. Furthermore, hosting is entirely on EU servers, which guarantees 100% GDPR-compliant processing without personal data.

### **How do the costs of Minds compare to traditional market research panels?**

Minds offers deep qualitative and quantitative insights at a fraction of the cost of a traditional panel, as the time-consuming and expensive recruitment of individual physical participants is completely eliminated.

### **How do these simulation results help overcome barriers to e-prescription adoption?**

By detailed analysis of the barriers in the Gematik ecosystem, digital health platforms can specifically optimize their onboarding flows to effectively convince chronically ill patients in the middle of the funnel (MoFu) stage.

## **About Minds**

Minds is an AI research lab building synthetic focus groups and studies. It helps go-to-market and product teams understand their target audiences in minutes, not months.

[**~~Learn more about Minds~~**](https://getminds.ai/)